Muller Kevin Silva, Tibúrcio Felipe Cantore, Ferreira Rui Seabra, Barraviera Benedito, Matheus Selma Maria Michelin
Department of Structural and Functional Biology, São Paulo State University (UNESP), Botucatu Institute of Biosciences, Botucatu, SP, Brazil.
Botucatu Medical School, São Paulo State University (UNESP), Botucatu, SP, Brazil.
J Venom Anim Toxins Incl Trop Dis. 2024 Apr 15;30:e20230060. doi: 10.1590/1678-9199-JVATITD-2023-0060. eCollection 2024.
Nerve injuries present a substantial challenge within the medical domain due to their prevalent occurrence and significant impact. In nerve injuries, a range of physiopathological and metabolic responses come into play to stabilize and repair the resulting damage. A critical concern arises from the disruption of connections at neuromuscular junctions, leading to profound degeneration and substantial loss of muscle function, thereby hampering motor tasks. While end-to-end neurorrhaphy serves as the established technique for treating peripheral nerve injuries, achieving comprehensive morphofunctional recovery remains a formidable challenge. In pursuit of enhancing the repair process, alternative and supportive methods are being explored. A promising candidate is the utilization of heterologous fibrin biopolymer, a sealant devoid of human blood components. Notably, this biopolymer has showcased its prowess in establishing a stable and protective microenvironment at the site of use in multiple scenarios of regenerative medicine. Hence, this scoping review is directed towards assessing the effects of associating heterologous fibrin biopolymer with neurorrhaphy to treat nerve injuries, drawing upon findings from prior studies disseminated through PubMed/MEDLINE, Scopus, and Web of Science databases. Further discourse delves into the intricacies of the biology of neuromuscular junctions, nerve injury pathophysiology, and the broader utilization of fibrin sealants in conjunction with sutures for nerve reconstruction procedures. The association of the heterologous fibrin biopolymer with neurorrhaphy emerges as a potential avenue for surmounting the limitations associated with traditional sealants while also mitigating degeneration in nerves, muscles, and NMJs post-injury, thereby fostering a more conducive environment for subsequent regeneration. Indeed, queries arise regarding the long-term regenerative potential of this approach and its applicability in reconstructive surgeries for human nerve injuries.
神经损伤因其普遍发生和重大影响,在医学领域构成了重大挑战。在神经损伤中,一系列生理病理和代谢反应会发挥作用,以稳定和修复由此产生的损伤。一个关键问题源于神经肌肉接头处连接的中断,导致严重的退化和肌肉功能的大量丧失,从而妨碍运动任务。虽然端端神经缝合术是治疗周围神经损伤的既定技术,但实现全面的形态功能恢复仍然是一项艰巨的挑战。为了加强修复过程,人们正在探索替代和辅助方法。一种有前景的候选方法是利用异源纤维蛋白生物聚合物,一种不含人类血液成分的密封剂。值得注意的是,这种生物聚合物在多种再生医学场景中的使用部位建立稳定和保护性微环境方面已展示出其优势。因此,本综述旨在评估将异源纤维蛋白生物聚合物与神经缝合术联合用于治疗神经损伤的效果,借鉴通过PubMed/MEDLINE、Scopus和Web of Science数据库传播的先前研究结果。进一步的论述深入探讨了神经肌肉接头生物学、神经损伤病理生理学的复杂性,以及纤维蛋白密封剂与缝线联合用于神经重建手术的更广泛应用。异源纤维蛋白生物聚合物与神经缝合术的联合应用成为克服传统密封剂相关局限性的潜在途径,同时还能减轻损伤后神经、肌肉和神经肌肉接头的退化,从而为后续再生营造更有利的环境。确实,关于这种方法的长期再生潜力及其在人类神经损伤重建手术中的适用性也出现了疑问。